Nublexa Tablet
Marketer
Bayer Zydus Pharma Pvt Ltd
Salt Composition
Regorafenib (40mg)
Overview Nublexa Tablet
Colon and rectal cancer patients may be prescribed Nublexa tablets, a tyrosine kinase inhibitor. Optimal absorption is achieved when taken with food, consistently at the same time daily. Dosage and frequency are determined by your physician based on your individual needs and may adjust over time; adhere strictly to their instructions. Incorrect usage or overdosing can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include infections, thrombocytopenia, anemia, reduced appetite, bleeding, hypertension, altered voice, diarrhea, mouth sores, nausea, vomiting, bilirubinuria, elevated liver enzymes, rash, fatigue, pain, pyrexia, mucositis, and weight loss. Report any concerning side effects promptly. Regular blood tests monitoring blood counts and liver function are essential. Inform your healthcare provider of all other medications you are taking, as interactions are possible. Nublexa is contraindicated during pregnancy and lactation; reliable contraception is crucial for both partners throughout treatment.
Uses of Nublexa Tablet
Colorectal cancer
Major Benefits of Nublexa Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Nublexa Tablet with a meal.
Common Side effects of Nublexa Tablet:
- Infection
- Low blood platelets
- Anemia (low number of red blood cells)
- Rash
- Weakness
- Vomiting
- Pain
- Nausea
- Fever
- Diarrhea
- High blood pressure
- Decreased appetite
- Mucosal inflammation
- Stomatitis (Inflammation of the mouth)
- Increased liver enzymes
- Weight loss
- Voice change
- Bilirubin in urine
How to use Nublexa Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Nublexa Tablet with a meal.
How Nublexa Tablet works:
Oncolex tablets are an anti-neoplastic agent. Their mechanism of action involves inhibiting the activity of a rogue protein responsible for signaling cancerous proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Nublexa Tablet with alcohol is undefined; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Taking Nublexa Tablet during pregnancy is considered unsafe due to proven harm to the unborn child. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known risks. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Nublexa Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Nublexa Tablet on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can generally use Nublexa tablets without dose modification. Nevertheless, data regarding Nublexa tablet use in individuals with severely impaired kidney function is scarce.
LiverCAUTION
Patients with liver impairment should use Nublexa Tablets cautiously, potentially requiring dosage modification. Liver function should be regularly monitored during treatment, and consultation with a physician is essential. Nublexa Tablets are contraindicated in those with severe hepatic disease.
What if you forget to take Nublexa Tablet :
NA
Facts to Know About Nublexa Tablet
| Label | Value |
|---|---|
| Type of Compound | Diaryl ether compound |
| Potential for Dependence | None. |
| Treatment Category | Cancer-fighting medications |
| Mechanism of Action | Kinase inhibitors targeting tyrosine |


